| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 5,875,212 | $587,579,968.00 | 2.83% |
| U.S. Treasury 4.00% 11/15/2035 | Fixed Income | 238,400,000 | $235,159,238.00 | 1.13% |
| TREASURY NOTE 3.5% 12-31-30 | Fixed Income | 132,623,200 | $132,017,072.00 | 0.63% |
| Goldman Sachs Group, Inc. 4.939% 10/21/2036 (USD-SOFR + 1.33% on 10/21/2035) | Fixed Income | 115,810,000 | $115,011,258.00 | 0.55% |
| Morgan Stanley 4.892% 10/22/2036 (USD-SOFR + 1.314% on 10/22/2035) | Fixed Income | 94,867,000 | $94,063,382.00 | 0.45% |
| MPT Operating Partnership, LP 8.50% 2/15/2032 | Fixed Income | 75,729,000 | $80,929,916.00 | 0.39% |
| AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 74,959,000 | $77,059,501.00 | 0.37% |
| Connect Finco SARL 9.00% 9/15/2029 | Fixed Income | 72,270,000 | $76,749,945.00 | 0.37% |
| Mars, Inc. 5.20% 3/1/2035 | Fixed Income | 66,754,000 | $68,636,129.00 | 0.33% |
| Ford Motor Credit Co., LLC 6.50% 2/7/2035 | Fixed Income | 59,205,000 | $61,358,641.00 | 0.3% |
| Peraton Corp., Term Loan B, (3-month USD CME Term SOFR + 3.85%) 7.69% 2/1/2028 | Fixed Income | 66,234,517 | $61,611,877.00 | 0.3% |
| NFE Financing, LLC 12.00% 11/15/2029 | Fixed Income | 209,996,299 | $60,898,927.00 | 0.29% |
| Oracle Corp. 5.50% 8/3/2035 | Fixed Income | 61,151,000 | $59,953,358.00 | 0.29% |
| Takeda U.S. Financing, Inc. 5.20% 7/7/2035 | Fixed Income | 59,751,000 | $60,886,747.00 | 0.29% |
| CVS Health Corp. 5.45% 9/15/2035 | Fixed Income | 57,307,000 | $58,681,623.00 | 0.28% |